| ECF | 1) Eosinophilic Chemotatic Factors 2) Extra-Cellular Fluid; ¼¼Æ÷ ¿Ü¾× |
|---|---|
| NCF | Neutrophilic Chemotatic Factors |
| CDSRF | chronic disease and sociodemographic risk factors |
| CSPINE | corticosteroid use, seropositive RA, peripheral joint destruction, involvement of cervical nerves, n... |
| FI, FII, | etc. factors I, II, etc. |
| C-terminal leucine protein methyltransferase | <enzyme> Reversibly modifies protein phosphatase 2a by methyl esterification at its c-terminal leucine residues Registry number: EC 2.1.1.- Synonym: tlp methyltransferase (26 Jun 1999) |
|---|---|
| enkephalin, leucine | <chemical> Tyrosylglycylglycylphenylalanylleucine. Endogenous pentapeptide with morphine-like activity. The amino acid in position 5 is leucine. Chemical name: L-Leucine, N-(N-(N-(N-L-tyrosylglycyl)glycyl)-L-phenylalanyl)- (12 Dec 1998) |
| enkephalin, leucine-2-alanine | <chemical> N-(n-(n-(n-l-tyrosyl-d-alanyl)glycyl)-l-phenylalanyl)-d-leucine. A synthetic delta-selective opioid peptide with analgesic properties. Treatment with dadle results in transient depression of mean arterial blood pressure and heart rate. Chemical name: D-Leucine, N-(N-(N-(N-L-tyrosyl-D-alanyl)glycyl)-L-phenylalanyl)- (12 Dec 1998) |
| leucine | <amino acid> The most abundant amino acid found in proteins. Confers hydrophobicity and has a structural rather than a chemical role. (18 Nov 1997) |
| leucine 2,3-aminomutase | <enzyme> Leucine is converted to 3-amino-4-methylpentanoate (beta leucine) Registry number: EC 5.4.3.7 (26 Jun 1999) |
| leucine acetyltransferase | <enzyme> Forms acetyl-l-leucine from acetyl-CoA plus leucine Registry number: EC 2.3.1.- Synonym: leucine acyltransferase (26 Jun 1999) |
| leucine aminopeptidase | <enzyme> An exopeptidase that removes neutral amino acid residues from the N terminus of proteins. (18 Nov 1997) |
| leucine dehydrogenase | <enzyme> An enzyme that catalyses the reaction of l-leucine, water, and NAD+ to produce NADH, ammonia, and 4-methyl-2-oxopentanoate; used in the treatment of certain tumours. (05 Mar 2000) |
| leucine hypoglycaemia | Reduction in blood glucose concentration produced by administration of leucine; believed to reflect the ability of this amino acid to stimulate insulin secretion. (05 Mar 2000) |
| leucine-induced hypoglycaemia | Rare cause of hypoglycaemia occurring following ingestion of leucine. Seen especially in infants. (05 Mar 2000) |
| leucine-trna ligase | <enzyme> An enzyme that activates leucine with its specific transfer RNA. Chemical name: L-Leucine:tRNA(Leu) ligase (AMP-forming) Registry number: EC 6.1.1.4 (12 Dec 1998) |
| leucine zippers | Domains in DNA-binding proteins that contain amino acid sequences that show periodic arrays of leucine residues. These residues exist in an alpha-helical conformation, with the leucine side chains extending from one alpha helix interdigitating with those displayed from a similar alpha helix of a second polypeptide, facilitating dimerization. (12 Dec 1998) |
| basic | 1. <chemistry> Relating to a base; performing the office of a base in a salt. Having the base in excess, or the amount of the base atomically greater than that of the acid, or exceeding in proportion that of the related neutral salt. Apparently alkaline, as certain normal salts which exhibit alkaline reactions with test paper. 2. <chemical> Said of crystalline rocks which contain a relatively low percentage of silica, as basalt. <chemistry> Basic salt, a salt formed from a base or hydroxide by the partial replacement of its hydrogen by a negative or acid element or radical. Source: Websters Dictionary (01 Mar 1998) |
| basic amino acid | An amino acid containing a second basic group (usually an amino group); e.g., lysine, arginine, ornithine. Synonym: dibasic amino acid. (05 Mar 2000) |
| basic anhydride | <chemical> A chemical (usually the oxide of a metal) which forms a base when it is mixed with water. (09 Oct 1997) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|